Toggle sidebar
定价
登录
Bristol Myers to Acquire RayzeBio in Deal Valued at $4.1 Billion
百时美施贵宝(US:BMY)
Barrons
·
2023-12-26 15:16
Bristol Myers to Acquire RayzeBio in Deal Valued at $4.1 Billion ...
Bristol-Myers Squibb-Bristol Myers to Acquire RayzeBio in Deal Valued at $4.1 Billion - Reportify